Research Nurse Coordinator Kendall Knobeloch, BSN, RN, and Research Nurse Practitioner Kristi Arnolds, RN, MSN, ANP-BC attended the AMBER HFpEF Investigator Meeting in Miami, Florida.
Kendall and Kristi were asked to be on a panel to discuss their successful enrollment strategies. Dr. Hartupee is the PI for this trial and WashU is one of the top enrolling sites.
Per the AMBER HFpEF website:
“In HFpEF, the heart muscle works harder to pump blood to the body. CK-4021586 may help reduce symptoms of HFpEF by decreasing excess pumping and improving relaxation of the heart muscle.
The purposes of the study are to learn about the safety and how well participants tolerate various doses of CK-4021586 when taken by mouth over time, to learn how the study drug interacts with the body at different doses, and how the body’s heart function responds to CK-4021586.”